- Home
- BHAT vs APRE Comparison
BHAT vs APRE Comparison
Compare BHAT & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- APRE
- Stock Information
- Founded
- BHAT 2010
- APRE 2006
- Country
- BHAT China
- APRE United States
- Employees
- BHAT N/A
- APRE N/A
- Industry
- BHAT Recreational Games/Products/Toys
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BHAT Consumer Discretionary
- APRE Health Care
- Exchange
- BHAT Nasdaq
- APRE Nasdaq
- Market Cap
- BHAT 10.3M
- APRE 9.7M
- IPO Year
- BHAT 2019
- APRE 2019
- Fundamental
- Price
- BHAT $1.88
- APRE $1.86
- Analyst Decision
- BHAT
- APRE Strong Buy
- Analyst Count
- BHAT 0
- APRE 2
- Target Price
- BHAT N/A
- APRE $15.50
- AVG Volume (30 Days)
- BHAT 142.6K
- APRE 26.5K
- Earning Date
- BHAT 04-30-2025
- APRE 05-14-2025
- Dividend Yield
- BHAT N/A
- APRE N/A
- EPS Growth
- BHAT N/A
- APRE N/A
- EPS
- BHAT N/A
- APRE N/A
- Revenue
- BHAT $18,724,190.00
- APRE $1,284,475.00
- Revenue This Year
- BHAT N/A
- APRE N/A
- Revenue Next Year
- BHAT N/A
- APRE N/A
- P/E Ratio
- BHAT N/A
- APRE N/A
- Revenue Growth
- BHAT N/A
- APRE 33.27
- 52 Week Low
- BHAT $1.65
- APRE $1.41
- 52 Week High
- BHAT $145.00
- APRE $5.90
- Technical
- Relative Strength Index (RSI)
- BHAT 41.13
- APRE 56.74
- Support Level
- BHAT $1.78
- APRE $1.45
- Resistance Level
- BHAT $2.00
- APRE $1.70
- Average True Range (ATR)
- BHAT 0.15
- APRE 0.16
- MACD
- BHAT 0.02
- APRE 0.03
- Stochastic Oscillator
- BHAT 23.81
- APRE 73.21
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.